# Ropivacaine For Post-POEM Pain Control

> **NCT03702647** · NA · COMPLETED · sponsor: **Lawrence Charles Hookey** · enrollment: 20 (actual)

## Conditions studied

- Achalasia
- Esophageal Achalasia

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03702647
- **Lead sponsor:** Lawrence Charles Hookey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-01-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702647, "Ropivacaine For Post-POEM Pain Control". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03702647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*